Nakashima Takahiro, Hashiba Katsutaka, Kikuchi Migaku, Yamaguchi Junichi, Kojima Sunao, Hanada Hiroyuki, Mano Toshiaki, Yamamoto Takeshi, Tanaka Akihito, Matsuo Kunihiro, Nakayama Naoki, Nomura Osamu, Matoba Tetsuya, Tahara Yoshio, Nonogi Hiroshi
Department of Emergency Medicine and Michigan Center for Integrative Research in Critical Care, University of Michigan Ann Arbor, MI USA.
Department of Cardiology, Saiseikai Yokohama-shi Nanbu Hospital Yokohama Japan.
Circ Rep. 2022 Apr 15;4(5):187-193. doi: 10.1253/circrep.CR-22-0003. eCollection 2022 May 10.
To achieve early reperfusion therapy for ST-elevation myocardial infarction (STEMI), proper and prompt patient transportation and activation of the catheterization laboratory are required. We investigated the efficacy of prehospital 12-lead electrocardiogram (ECG) acquisition and destination hospital notification in patients with STEMI. This is a systematic review of observational studies. We searched the PubMed database from inception to March 2020. Two reviewers independently performed literature selection. The critical outcome was short-term mortality. The important outcome was door-to-balloon (D2B) time. We used the GRADE approach to assess the certainty of the evidence. For the critical outcome, 14 studies with 29,365 patients were included in the meta-analysis. Short-term mortality was significantly lower in the group with prehospital 12-lead ECG acquisition and destination hospital notification than in the control group (odds ratio 0.72; 95% confidence interval [CI] 0.61-0.85; P<0.0001). For the important outcome, 10 studies with 2,947 patients were included in the meta-analysis. D2B time was significantly shorter in the group with prehospital 12-lead ECG acquisition and destination hospital notification than in the control group (mean difference -26.24; 95% CI -33.46, -19.02; P<0.0001). Prehospital 12-lead ECG acquisition and destination hospital notification is associated with lower short-term mortality and shorter D2B time than no ECG acquisition or no notification among patients with suspected STEMI outside of a hospital.
为实现ST段抬高型心肌梗死(STEMI)的早期再灌注治疗,需要妥善、迅速地转运患者并启动导管室。我们研究了院前12导联心电图(ECG)采集及向目标医院通报情况对STEMI患者的疗效。这是一项对观察性研究的系统评价。我们检索了自数据库建立至2020年3月的PubMed数据库。两名评价员独立进行文献筛选。关键结局为短期死亡率。重要结局为门球时间(D2B)。我们采用GRADE方法评估证据的确定性。对于关键结局,纳入荟萃分析的有14项研究,共29365例患者。院前采集12导联ECG并向目标医院通报情况的组短期死亡率显著低于对照组(比值比0.72;95%置信区间[CI] 0.61 - 0.85;P<0.0001)。对于重要结局,纳入荟萃分析的有10项研究,共2947例患者。院前采集12导联ECG并向目标医院通报情况的组D2B时间显著短于对照组(平均差值 -26.24;95% CI -33.46,-19.02;P<0.0001)。与未进行ECG采集或未通报情况相比,院外疑似STEMI患者进行院前12导联ECG采集并向目标医院通报情况与更低的短期死亡率及更短的D2B时间相关。